Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SONATA-HCM trial of sotagliflozin in symptomatic hypertrophic cardiomyopathy
MOH_2025-01-22_013676Phase 3Not yet recruiting
- Sponsor
- Lexicon Pharmaceuticals, Inc.
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hypertrophic cardiomyopathy (HCM) comparing Sotagliflozin with Placebo (2 arms). Planned start Nov 2024; status: not yet recruiting.
02
Drugs
sotagliflozin
03
Conditions
hypertrophic cardiomyopathy (HCM)
Beyond the preview
Go deeper on MOH_2025-01-22_013676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2025-01-22_013676.